Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Roivant Sciences Ltd. Director's Dealing 2019

Nov 27, 2019

30587_dirs_2019-11-27_d798fb33-cb17-4c66-bce4-2ba28cda0018.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Myovant Sciences Ltd. (MYOV)
CIK: 0001679082
Period of Report: 2019-11-25

Reporting Person: Roivant Sciences Ltd. (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-11-25 Common Shares, par value $0.000017727 per share P 3500000 $15.00 Acquired 44509411 Direct

Footnotes

F1: On November 25, 2019, the Reporting Person entered into a stock purchase agreement with a third party pursuant to which the Reporting Person agreed to purchase an aggregate of 3,500,000 Common Shares from such third party for a purchase price equal to $15.00 per Common Share. The stock purchase agreement provides that these Common Shares will be delivered to the Reporting Person within 10 calendar days following execution of the stock purchase agreement (or a later date as mutually agreed by the parties).